As a proof-of-principle we selected a malignant estrogen receptor (ER)-positive breast cancer epithelial cell line, MCF-7, and a non-malignant breast epithelial control cell line, MCF-10A, for comparison. This evidence concerns the gene ESR1 and breast carcinoma.